Topoisomerase-II alpha expression as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples